Sugi Predict

Sugi Predict / Compounds / SCHEMBL7076295

SCHEMBL7076295

SCHEMBL7076295

C(=C/c1ccccc1)\CN(C/C=C/c1ccccc1)Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ NR1I2 O75469 1/20 0.47
▸ DRD2 P14416 1/20 0.47
▸ ADRA2C P18825 1/20 0.47
▸ CNR1 P21554 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ HTR2A P28223 1/20 0.47
▸ SLC6A4 P31645 1/20 0.47
▸ ADRA1A P35348 1/20 0.47
▸ OPRK1 P41145 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ EBP Q15125 1/20 0.47
▸ SIGMAR1 Q99720 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8989760 1.00 MEN1 (0.54) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL1931710 0.96 MEN1 (0.54) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL1931712 0.96 MEN1 (0.54) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL7078604 0.91 MEN1 (0.47) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL7078602 0.91 MEN1 (0.47) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL9779068 0.89 MEN1 (0.53) MEN1KMT2ANR1I2DRD2ADRA2C
Hydrochloric Acid SCHEMBL8070534 0.88 MEN1 (0.51) MEN1KMT2AKCNH2TSHRATM
SCHEMBL8223120 0.86 MEN1 (0.50) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL2774560 0.85 MEN1 (0.63) MEN1KMT2ANR1I2DRD2ADRA2C
SCHEMBL2774559 0.85 MEN1 (0.63) MEN1KMT2ANR1I2DRD2ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740658-B1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES USED, FOR EXAMPLE, AS NEUROLEPTICS ABBOTT GMBH & CO KG (DE) 2003-07-02 — — EP disclosed
US-5616705-A N-substituted azabicycloheptane derivatives, their preparation and use BASF AKTIENGESELLSCHAFT (DE) 1997-04-01 — — US disclosed
EP-0646113-B1 SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATES USEFUL AS INTERMEDIATE PRODUCTS BASF AG (DE) 1996-12-18 — — EP disclosed
EP-0740658-A1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES USED, FOR EXAMPLE, AS NEUROLEPTICS BASF AKTIENGESELLSCHAFT (DE) 1996-11-06 — — EP disclosed
EP-0646110-B1 N-SUBSTITUTED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS BASF AG (DE) 1996-10-23 — — EP disclosed
US-5521209-A N-substituted azabicyclo[3.2.0]heptane derivatives as neuroleptics, the preparation and use thereof BASF AKTIENGESELLSCHAFT (DE) 1996-05-28 — — US disclosed
US-5473080-A Substituted azabicycloheptane derivatives, their preparation and use BASF AKTIENGESELLSCHAFT (DE) 1995-12-05 — — US disclosed
WO-1995015312-A1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES USED, FOR EXAMPLE, AS NEUROLEPTICS BASF AKTIENGESELLSCHAFT (DE) 1995-06-08 — — WO disclosed
EP-0646110-A1 N-SUBSTITUED 3-AZABICYCLO 3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS ETC. BASF AG (DE) 1995-04-05 — — EP disclosed
EP-0646113-A1 SUBSTITUED 3-AZABICYCLO 3.2.0]HEPTANE DERIVATES USEFUL AS INTERMEDIATE PRODUCTS. BASF AG (DE) 1995-04-05 — — EP disclosed
WO-1994000431-A1 N-SUBSTITUED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATIVES USEFUL AS NEUROLEPTIC AGENTS ETC. BASF AKTIENGESELLSCHAFT (DE) 1994-01-06 — — WO disclosed
WO-1994000445-A1 SUBSTITUED 3-AZABICYCLO[3.2.0]HEPTANE DERIVATES USEFUL AS INTERMEDIATE PRODUCTS BASF AKTIENGESELLSCHAFT (DE) 1994-01-06 — — WO disclosed